Pharmacoepidemiology and Drug Safety

Journal

Publication Venue For

  • Recent tapering from long-term opioid therapy and odds of opioid-related hospital use 2022
  • Hepatitis B vaccine and risk of acute myocardial infarction among individuals with diabetes mellitus.  30:1441-1446. 2021
  • Using negative control outcomes to assess the comparability of treatment groups among women with osteoporosis in the United States.  29:854-863. 2020
  • Capture of biologic and biosimilar dispensings in a consortium of U.S.-based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claims.  29:778-785. 2020
  • Mapping from the International Classification of Diseases (ICD) 9th to 10th Revision for Research in Biologics and Biosimilars Using Administrative Healthcare Data.  29:770-777. 2020
  • Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars.  29:757-769. 2020
  • Incorporating patient generated health data into pharmacoepidemiological research 2020
  • National trends in hydroxyurea and opioid prescribing for sickle cell disease by office-based physicians in the United States, 1997-2017.  28:1246-1250. 2019
  • Accuracy of a composite event definition for hypoglycemia.  28:625-631. 2019
  • Development of algorithms for identifying fatal cardiovascular disease in Medicare claims.  27:740-750. 2018
  • Improving medical record retrieval for validation studies in Medicare data.  26:393-401. 2017
  • The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights.  26:310-319. 2017
  • Agreement between Medicare pharmacy claims, self-report, and medication inventory for assessing lipid-lowering medication use.  25:827-835. 2016
  • Red blood cell transfusion, hyperkalemia, And heart failure in advanced chronic kidney disease.  24:654-662. 2015
  • RE: Drug risk assessment and data reuse.  23:109-110. 2014
  • Identifying newly approved medications in Medicare claims data: A case study using tocilizumab.  22:1214-1221. 2013
  • Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia® (denosumab) for the treatment of postmenopausal osteoporosis.  22:1107-1114. 2013
  • Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs.  22:1036-1045. 2013
  • Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009.  22:842-849. 2013
  • Identifying suicidal behavior among adolescents using administrative claims data.  22:769-775. 2013
  • Increasing use of atypical antipsychotics and anticonvulsants during pregnancy.  22:794-801. 2013
  • Association between anti-TNF-α therapy and interstitial lung disease.  22:394-402. 2013
  • Generic alendronate use among medicare beneficiaries: Are part d data complete?.  22:55-63. 2013
  • Association between anti-TNF-α therapy and all-cause mortality.  21:1311-1320. 2012
  • Comparative safety of infliximab and etanercept on the risk of serious infections: Does the association vary by patient characteristics?.  21:524-534. 2012
  • A systematic review of validated methods for identifying orthopedic implant removal and revision using administrative data.  21:265-273. 2012
  • Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems.  20:1199-1209. 2011
  • Validation of ICD-9-CM codes to identify gastrointestinal perforation events in administrative claims data among hospitalized rheumatoid arthritis patients.  20:1150-1158. 2011
  • The relationship between computerized physician order entry and pediatric adverse drug events: A nested matched case-control study.  18:751-755. 2009
  • Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users.  15:710-718. 2006
  • Unbalanced regulation of over-the-counter analgesics: The lesser of two evils?.  15:410-411. 2006
  • Documented tuberculin skin testing among infliximab users following a multi-modal risk communication interventions.  15:11-18. 2006

    • International Standard Serial Number (issn)

  • 1053-8569

    • Electronic International Standard Serial Number (eissn)

  • 1099-1557